Antonio D'Avolio Selected Research

2,2- (2- chlorophenyl- 4'- chlorophenyl)acetic acid

11/2017

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio D'Avolio Research Topics

Disease

30	Infections 09/2023 - 01/2008
17	Chronic Hepatitis C 01/2022 - 10/2013
12	Chronic Hepatitis B 08/2022 - 01/2013
9	COVID-19 05/2023 - 01/2020
9	Critical Illness (Critically Ill) 12/2022 - 10/2013
8	Hypertension (High Blood Pressure) 04/2024 - 03/2014
7	Fibrosis (Cirrhosis) 01/2022 - 01/2013
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 09/2014
5	Anemia 01/2021 - 07/2012
4	Disease Progression 07/2023 - 03/2014
4	Invasive Fungal Infections 06/2020 - 10/2017
4	Cryoglobulinemia 04/2018 - 02/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2017 - 06/2009
4	Hepatitis B 05/2017 - 02/2013
3	Inflammation (Inflammations) 03/2024 - 01/2023
3	Crohn Disease (Crohn's Disease) 01/2024 - 01/2021
3	Endocarditis 10/2022 - 09/2019
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 01/2013
3	Burns 09/2021 - 01/2017
3	HIV Infections (HIV Infection) 05/2021 - 07/2014
3	Adrenocortical Carcinoma 01/2021 - 06/2013
3	Sepsis (Septicemia) 09/2019 - 08/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2013
3	Hemolytic Anemia 09/2014 - 07/2012
2	Mental Disorders (Mental Disorder) 09/2023 - 12/2022
2	Pain (Aches) 07/2022 - 01/2020
2	Hyperbilirubinemia 01/2022 - 01/2017
2	Pneumonia (Pneumonitis) 12/2021 - 10/2013
2	Hemochromatosis (Bronze Diabetes) 10/2019 - 12/2016
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Mucormycosis 01/2019 - 10/2017
2	Central Nervous System Infections (Central Nervous System Infection) 12/2018 - 12/2010
2	Iron Overload 01/2018 - 12/2016
2	Septic Shock (Toxic Shock Syndrome) 03/2017 - 12/2013
2	Proteinuria 11/2016 - 03/2014
2	Communicable Diseases (Infectious Diseases) 07/2014 - 01/2014

Drug/Important Bio-Agent (IBA)

17	Vitamin D FDA LinkGeneric 01/2024 - 03/2014
17	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 07/2012
12	InterferonsIBA 04/2018 - 09/2013
11	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2013
6	entecavir FDA Link 01/2018 - 01/2013
6	Hepatitis B e AntigensIBA 01/2018 - 01/2013
6	telaprevirIBA 11/2015 - 09/2013
5	Tenofovir (Viread)FDA Link 01/2023 - 10/2015
5	Protease Inhibitors (Protease Inhibitor)IBA 02/2017 - 07/2014
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2021
4	dalbavancinIBA 09/2022 - 11/2019
4	remdesivirIBA 12/2021 - 01/2020
4	SofosbuvirIBA 01/2021 - 01/2017
4	Voriconazole (Vfend)FDA LinkGeneric 06/2020 - 07/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 10/2013
4	IronIBA 01/2018 - 11/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2013
4	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 06/2009
4	InterleukinsIBA 01/2017 - 02/2014
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2016 - 04/2013
4	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 11/2015 - 09/2014
3	dolutegravirIBA 01/2023 - 01/2017
3	Daptomycin FDA Link 10/2022 - 08/2016
3	Mitotane (Lysodren)FDA Link 01/2021 - 06/2013
3	TriazolesIBA 06/2020 - 10/2017
3	Deferasirox FDA Link 01/2018 - 11/2016
3	Vitamin D3 24-HydroxylaseIBA 01/2018 - 01/2015
3	nilotinib FDA Link 10/2017 - 06/2009
3	Linezolid (Zyvox)FDA Link 03/2017 - 10/2013
3	Raltegravir Potassium FDA Link 01/2017 - 05/2011
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2017 - 12/2008
3	CreatinineIBA 11/2016 - 10/2015
2	CannabinoidsIBA 05/2024 - 07/2022
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2018
2	Serum AlbuminIBA 03/2024 - 02/2023
2	CefiderocolIBA 11/2023 - 12/2022
2	Opioid Analgesics (Opioids)IBA 06/2023 - 11/2021
2	Emtricitabine (Emtriva)FDA Link 01/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2022 - 01/2021
2	LipoglycopeptidesIBA 09/2022 - 09/2021
2	Monoclonal AntibodiesIBA 11/2021 - 01/2019
2	NucleosidesIBA 05/2021 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 03/2016
2	daclatasvirIBA 01/2021 - 01/2018
2	GS-441524IBA 10/2020 - 01/2020
2	ProdrugsIBA 01/2020 - 10/2015
2	Meropenem (Merrem)FDA LinkGeneric 01/2020 - 04/2015
2	EchinocandinsIBA 09/2019 - 12/2013
2	Azathioprine (Imuran)FDA LinkGeneric 08/2019 - 09/2014
2	isavuconazoleIBA 01/2019 - 10/2017
2	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2010
2	Inosine TriphosphataseIBA 09/2017 - 10/2013
2	SimeprevirIBA 06/2017 - 01/2017
2	peginterferon alfa-2a (Pegasys)FDA Link 12/2016 - 02/2014
2	nasIBA 12/2016 - 11/2016
2	Interferon-alpha (Interferon Alfa)IBA 11/2016 - 09/2014
2	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 04/2015 - 01/2015
2	Maraviroc FDA Link 05/2014 - 05/2011
2	Dasatinib (BMS 354825)FDA Link 02/2012 - 06/2009
2	Tyrosine Kinase InhibitorsIBA 02/2012 - 06/2009

Therapy/Procedure

38	Therapeutics 04/2024 - 12/2010
2	Denervation 04/2024 - 11/2018
2	Off-Label Use 09/2022 - 09/2021
2	Contraindications 01/2017 - 08/2015